3
Clinical Trials associated with CG-BM1 Allogenic Bone marrow derived MSC (Guangzhou Cellgenes)一项评价CG-BM1异体人骨髓间充质干细胞注射液治疗缺血性脑卒中安全性和有效性的临床试验
[Translation] A clinical trial to evaluate the safety and efficacy of CG-BM1 allogeneic human bone marrow mesenchymal stem cell injection in the treatment of ischemic stroke
评价CG-BM1治疗缺血性脑卒中患者的安全性和耐受性,确定临床用药的安全范围。
[Translation] To evaluate the safety and tolerability of CG-BM1 in the treatment of patients with ischemic stroke and determine the safe range of clinical use.
一项评价CG-BM1异体人骨髓间充质干细胞注射液治疗慢加急性肝衰竭患者的安全性、耐受性和初步有效性临床试验
[Translation] A clinical trial to evaluate the safety, tolerability and preliminary efficacy of CG-BM1 allogeneic human bone marrow mesenchymal stem cell injection in the treatment of patients with acute-on-chronic liver failure
主要目的:评价CG-BM1治疗成人ACLF患者的安全性和耐受性,确定临床用药的安全范围。次要目的:观察CG-BM1治疗成人ACLF患者的初步有效性,为后续临床试验方案设计提供依据。
[Translation] Primary purpose: To evaluate the safety and tolerability of CG-BM1 in the treatment of adult ACLF patients and determine the safety range of clinical medication. Secondary purpose: To observe the preliminary efficacy of CG-BM1 in the treatment of adult ACLF patients and provide a basis for the design of subsequent clinical trial programs.
一项评价异体人骨髓间充质干细胞(CG-BM1)注射液治疗中、重度成人急性呼吸窘迫综合征患者的安全性、耐受性和初步有效性的Ⅰ期临床研究
[Translation] A Phase I clinical study to evaluate the safety, tolerability and preliminary efficacy of allogeneic human bone marrow mesenchymal stem cell (CG-BM1) injection in the treatment of moderate to severe adult acute respiratory distress syndrome
主要目的:评价CG-BM1治疗感染引起的中、重度成人ARDS患者的安全性和耐受性。
次要目的:评价CG-BM1治疗感染引起的中、重度成人ARDS患者的初步有效性。
[Translation] Primary objective: To evaluate the safety and tolerability of CG-BM1 in the treatment of moderate to severe adult ARDS caused by infection.
Secondary objective: To evaluate the preliminary efficacy of CG-BM1 in the treatment of moderate to severe adult ARDS caused by infection.
100 Clinical Results associated with CG-BM1 Allogenic Bone marrow derived MSC (Guangzhou Cellgenes)
100 Translational Medicine associated with CG-BM1 Allogenic Bone marrow derived MSC (Guangzhou Cellgenes)
100 Patents (Medical) associated with CG-BM1 Allogenic Bone marrow derived MSC (Guangzhou Cellgenes)
100 Deals associated with CG-BM1 Allogenic Bone marrow derived MSC (Guangzhou Cellgenes)